Skip to main content
International Journal of Vascular Medicine logoLink to International Journal of Vascular Medicine
. 2019 Nov 20;2019:7480780. doi: 10.1155/2019/7480780

Corrigendum to “Caffeine's Vascular Mechanisms of Action”

Darío Echeverri 1,, Félix R Montes 1, Mariana Cabrera 1, Angélica Galán 1, Angélica Prieto 1
PMCID: PMC7012199  PMID: 32089886

In the article titled “Caffeine's Vascular Mechanisms of Action” [1], there was an error in section “2. Metabolic Pathway of Caffeine and Its Metabolites,” where it refers to three metabolites: Paraxanthine, Theobromine, and Theophylline. However, in the second paragraph the three were actually mentioned as Paraxanthine and Theophylline twice as follows:

“Caffeine metabolism yields paraxanthine as a final product, which represents 72 to 80% of caffeine metabolism. There are five main metabolic pathways which contribute to caffeine metabolism in adults [13, 14]. The first three consist of demethylization of N-3 to form Paraxanthine, N-1 to form Theophylline (vasodilator, increased cerebral and muscular blood flow), and N-7 to form Theophylline (vascular, bronchiole, muscular, and respiratory relaxant).”

Accordingly, the paragraph should read as follows:

“Caffeine metabolism yields paraxanthine as a final product, which represents 72 to 80% of caffeine metabolism. There are five main metabolic pathways which contribute to caffeine metabolism in adults [13, 14]. The first three consist of demethylization of N-3 to form Paraxanthine, N-1 to form Theobromine (vasodilator, increased cerebral and muscular blood flow), and N-7 to form Theophylline (vascular, bronchiole, muscular, and respiratory relaxant).”

References

  • 1.Echeverri D., Montes F. R., Cabrera M., Galán A., Prieto A. Caffeine's vascular mechanisms of action. International Journal of Vascular Medicine. 2010;2010:10. doi: 10.1155/2010/834060.834060 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from International Journal of Vascular Medicine are provided here courtesy of Wiley

RESOURCES